Is BRC Therapeutics opening a new regulatory lane for cannabinoid-based CRPS therapies?
CRPS has no approved U.S. therapy. BRC-002 now has an FDA path, but proof of safety, efficacy, and dosing discipline still lies ahead.
Pharma & Biotech
Pharma & Biotech
Does MapLight Therapeutics, Inc. have the clinical design to compete in crowded neuropsychiatric markets?
MapLight Therapeutics nears key Phase 2 data in schizophrenia and autism. Discover how its trial design could shape CNS market competition.
Medical Devices & Diagnostics
Why PreludeDx’s second FDA breakthrough device designation matters for precision diagnostics
Breast cancer care needs sharper radiation decisions. PreludeDx’s AidaBREAST now faces the harder test of validation, adoption and access.
Medical Devices & Diagnostics
What Orchestra BioMed Holdings, Inc.’s AVIM strategy reveals about the future of hypertension device innovation
FDA backing boosts AVIM therapy momentum. Discover how Orchestra BioMed Holdings, Inc. is shaping the future of hypertension treatment.
Pharma & Biotech
Is Can-Fite BioPharma Ltd. building a differentiated niche in late-line pancreatic cancer therapy
Is Can-Fite BioPharma Ltd. carving a niche in pancreatic cancer? Explore how namodenoson’s Phase 2a data could reshape late-line treatment strategies.
Pharma & Biotech
What Chiesi’s $1.9bn KalVista deal reveals about the next phase of rare disease consolidation
Rare disease M&A is shifting from science risk to launch execution. Chiesi’s KalVista deal puts oral HAE therapy at the center.
Medical Devices & Diagnostics
Can Chest Wall Innovations turn FDA clearance into adoption in rib fixation?
Rib fixation is gaining clinical ground. Chest Wall Innovations now faces the harder test: converting FDA clearance into surgeon adoption.
Pharma & Biotech
Paradigm Health’s FDA collaboration puts clinical trial data automation under the spotlight
FDA review is moving closer to real time. Paradigm Health’s pilot with Amgen and AstraZeneca could reset clinical trial infrastructure.
Medical Devices & Diagnostics
Can Earflo reduce ear tube surgery pressure with its FDA-cleared pediatric device?
Pediatric ear care has long had a waiting-room problem. Earflo’s FDA-cleared device tests whether home therapy can close the gap.
Medical Devices & Diagnostics
Why Gemelli Biotech’s 3-gas breath test could reshape how clinicians evaluate SIBO
Gut diagnostics need proof, not buzz. Gemelli Biotech’s DDW 2026 visibility could test whether IBS and SIBO care is ready for precision tools.